NOS2 and neoplasm: The ratio of MDSCs from bone marrow, blood, spleen and tumor tissue and the mRNA levels of Arg1 and iNOS from splenic MDSCs were found to decrease in the group co-treated with anti-PD-1 and DIM compared with the single treatment group (Fig. 4D, E and Additional file 1: Fig. S1D, E).